The monitoring of a patient''s response to the treatment for cancer malignancies may now become easy thanks to a new microchip-based device developed by a research team. The team from the MGH Cancer Center and the Center for Systems Biology reports using their device to isolate and identify tumor cells from ascites, an accumulation of fluid in the abdomen that often occurs in abdominal cancers. The PNAS